more_reports

The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports

Biotech Firm Adjusts Placement Terms to Fuel U.S. Expansion

  ()
Canadian healthcare and clinical stage drug development company Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) updates the pricing and warrant terms for its previously announced non-brokered private placement. Read why one technical analyst thinks the stock is ready to break out.
Tags: Life Sciences Tools & DiagnosticsBiotechnology / PharmaceuticalsPsychedelics

AI-Powered Medical Education Suite Cuts Costs, whilst Enhancing Clinical Skills Training for Future Doctors

  ()
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) launched its enhanced medical education suite in Minnesota, showing strong reliability and providing schools with up to 40% cost savings. Read on to find out how AI-simulated patients are reshaping medical education and enhancing clinical skills at scale.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Healthcare Firm Uncovers AI Healthcare Growth Opportunity

  ()
Treatment.com AI Inc.'s (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) subsidiary Rocket Doctor was chosen by the Larta Institute to participate in its Bioscience and Healthcare Accelerator program. Read on to learn why one analyst says it is time to buy this company's stock.
Tags: Life Sciences Tools & DiagnosticsTechnology

Co. Poised to Begin Major New Bull Market

Contributed Opinion
  ()
Technical Analyst Clive Maund explains why he thinks Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is an Immediate Strong Buy.
Tags: TechnologySpecial SituationsLife Sciences Tools & DiagnosticsBiotechnology / Pharmaceuticals

Centrally Positioned AI Co. Platform Designed To Transform Healthcare

Contributed Opinion
  ()
Technical Analyst Clive Maund explains why he thinks now is an excellent time to buy or add to positions in Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA).
Tags: Life Sciences Tools & DiagnosticsTechnology

Biopharma Company Leverages AI-Powered Platform for Cancer Breakthroughs

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) announced its scientific advisor and collaborator Dr. Artem Cherkasov was recently recognized as a leader in AI-driven drug development. Find out which analysts recently initiated coverage on the company.
Tags: Biotechnology / PharmaceuticalsLife Sciences Tools & Diagnostics

Two Use Cases for AI in Healthcare

  ()
In both, proprietary software platforms analyze heaps of data, but one focuses on genetics, the other neurology. Learn more about the companies behind the technology.
Tags: TechnologyLife Sciences Tools & Diagnostics

AI Stock in an Uptrend That Is Likely To Continue

Contributed Opinion
  ()
Technical Analyst Clive Maund explains why he thinks Light AI Inc. (ALGO:CBOE) is an Immediate Strong Buy.
Tags: Medical DevicesLife Sciences Tools & Diagnostics

Tech Innovator Achieves Breakthrough Multi-Market Success

  ()
Clean technology company BioLargo Inc. (BLGO:OTCQX) announces it had a "widely successful" and "transformative" 2024 and is looking forward to more revenue growth in 2025. Read why one expert thinks investors should be doubling down on the stock.
Tags: Life Sciences Tools & DiagnosticsTechnologyMedical Devices

Showing Results: 1 to 9 of 9